|
- Pioneering mRNA technology - Moderna
Learn how we’re changing the world of medicine Discover career opportunities, our product pipeline, and browse media resources Meet Moderna
- Our Story - Moderna
Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease–human metapneumovirus (hMPV virus) and parainfluenza virus
- mRNA medicines we are currently developing
Track the development of Moderna’s mRNA medicines From preclinical development to commercial phase
- Company Culture - Moderna
Join Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine
- Our Mission Values - Moderna
Our Mindsets Alongside our Values, our Mindsets allow us to overcome challenges together We are working to build the best possible version of Moderna 20 years from now These Mindsets are tools we are using to build it, together See our mindsets
- Investor Relations - Moderna
Innovation Incubator New venture labs Terms of Use Site Map Privacy Policy Contact Moderna © 2025 Moderna, Inc
- News and Media – Moderna
Resources for journalists and media members The latest press releases by Moderna
- Modernas mRNA Platform - Moderna
In addition to mRNA vaccines, Moderna is working on other applications of potential mRNA therapeutics that could help people with cancer, metabolic diseases and more
|
|
|